Teva, Novartis Settle Suit Over Generic Famvir

Law360, New York (February 16, 2010, 1:35 PM EST) -- Israel-based Teva Pharmaceutical Industries Ltd.'s U.S. unit has settled a patent infringement suit brought by Novartis AG over a generic version of genital herpes drug Famvir.

Teva Pharmaceuticals USA Inc. will make a one-time payment to Novartis and pay ongoing royalties on future U.S. sales of the generic in exchange for a release from liability, Teva said.

No other terms were released, and a representative for Novartis could not immediately be reached for comment Tuesday. Settlement documents have not been filed in the case, which is...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.